Literature DB >> 27277455

Total and viable residual splenic volume measurement after partial splenic embolization by three-dimensional ultrasound.

Hisashi Hidaka1, Guoqin Wang2, Takahide Nakazawa3, Mitsuhiro Kida3, Michiko Yanagihara4, Shigeru Fujii4, Akitaka Shibuya3, Wasaburo Koizumi3.   

Abstract

PURPOSE: We prospectively evaluated the validity of total and viable residual splenic volume after partial splenic embolization (PSE) with three-dimensional (3D) ultrasound (US) measurement.
METHODS: Twenty patients with splenomegaly were included. All splenic volumes were measured with transabdominal US using virtual organ computer-aided analysis (VOCAL). The viable residual splenic volume after PSE was estimated by using contrast-enhanced (CE) US with VOCAL. The agreement of the measurements from VOCAL and computed tomography (CT) was confirmed using interclass correlation coefficients (ICCs) and Bland-Altman plots.
RESULTS: Mean volume was 503 ± 250 ml for total spleen and 209 ± 108 ml for viable residual volume. Regarding total volume, there was a high correlation and agreement (ICCs = 0.90) between 3D US and CT volumetry. Regarding viable residual volume, although there was a moderate correlation between 3D CEUS and CT volumetry, mean ICCs of 0.617 indicated poor agreement. With Bland-Altman plots, a narrow 95 % limit of agreement was observed among patients with a total volume under 1000 ml.
CONCLUSION: The total splenic volume could be accurately estimated with 3D US. However, estimation of viable residual splenic volume should be limited in cases with total splenic volume under 1000 ml.

Entities:  

Keywords:  Contrast-enhanced ultrasonography; Partial splenic embolization; Splenic volume; Splenomegaly; Three-dimensional ultrasound

Year:  2013        PMID: 27277455     DOI: 10.1007/s10396-013-0443-6

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  15 in total

Review 1.  Measuring agreement in medical informatics reliability studies.

Authors:  George Hripcsak; Daniel F Heitjan
Journal:  J Biomed Inform       Date:  2002-04       Impact factor: 6.317

2.  Heterogeneous staining in the liver parenchyma after the injection of perflubutane microbubble contrast agent.

Authors:  Taro Shimada; Hitoshi Maruyama; Tadashi Sekimoto; Hidehiro Kamezaki; Masanori Takahashi; Osamu Yokosuka
Journal:  Ultrasound Med Biol       Date:  2012-06-12       Impact factor: 2.998

3.  Reliability and validity of splenic volume measurement by 3-D ultrasound.

Authors:  Hisashi Hidaka; Takahide Nakazawa; Guoqin Wang; Shigehiro Kokubu; Tsutomu Minamino; Juichi Takada; Yoshiaki Tanaka; Yusuke Okuwaki; Masaaki Watanabe; Akitaka Shibuya; Wasaburo Koizumi
Journal:  Hepatol Res       Date:  2010-10       Impact factor: 4.288

4.  Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial.

Authors:  Fuminori Moriyasu; Kouichi Itoh
Journal:  AJR Am J Roentgenol       Date:  2009-07       Impact factor: 3.959

5.  Sonazoid-enhanced ultrasonography for the diagnosis of an intrapancreatic accessory spleen: a case report.

Authors:  Yuki Makino; Yasuharu Imai; Kazuto Fukuda; Yasushi Seki; Sachiyo Kogita; Yoshiyuki Sawai; Takumi Igura; Masanori Kurokawa; Manabu Takamura
Journal:  J Clin Ultrasound       Date:  2011-03-21       Impact factor: 0.910

6.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

7.  Volume determinations using computed tomography.

Authors:  R S Breiman; J W Beck; M Korobkin; R Glenny; O E Akwari; D K Heaston; A V Moore; P C Ram
Journal:  AJR Am J Roentgenol       Date:  1982-02       Impact factor: 3.959

8.  Volume of the spleen in children as measured on CT scans: normal standards as a function of body weight.

Authors:  A E Schlesinger; K A Edgar; L A Boxer
Journal:  AJR Am J Roentgenol       Date:  1993-05       Impact factor: 3.959

9.  Risk factors for complications after partial splenic embolization for liver cirrhosis.

Authors:  H Hayashi; T Beppu; K Okabe; T Masuda; H Okabe; H Baba
Journal:  Br J Surg       Date:  2008-06       Impact factor: 6.939

10.  Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis.

Authors:  Hiromitsu Hayashi; Toru Beppu; Kazutoshi Okabe; Toshiro Masuda; Hirohisa Okabe; Takatoshi Ishiko; Hideo Baba
Journal:  J Gastroenterol       Date:  2010-01-05       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.